Head-to-head · Cost-Efficiency Index
Curex vs Totara Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Curex
People who want a low-cost first month, an oral option, and a verified pharmacy nationwide, and don't need a dose-by-dose price table before signing up.
Visit CurexTotara Health
Shoppers who want a flat month-to-month GLP-1 price that doesn't climb with the dose, and the option of a tablet or drops instead of a shot.
Visit Totara HealthThe verdict
Curex takes it, leading the Cost-Efficiency Index 81 to 80. A discounted first month ($49-$149) steps up to a 'starting at $199' ongoing rate — real, but not the flat, fully-disclosed price the headline implies, and California loses the injectable route entirely. Totara Health still earns a B− — Shoppers who want a flat month-to-month GLP-1 price that doesn't climb with the dose, and the option of a tablet or drops instead of a shot.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Curex.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Curex | Totara Health |
|---|---|---|
| Cost-Efficiency Index | 81/100 | 80/100 |
| Semaglutide / mo | $199/moStarting (first month $49) | $190/mo1-month plan, same price at every dose, compounded |
| Tirzepatide / mo | $199/moStarting (first month $149) | $239/mo1-month plan, same price at every dose, compounded |
| Semaglutide / yr (modeled) | $2,388 | $2,280 |
| Tirzepatide / yr (modeled) | $2,388 | $2,868 |
| Coverage | All 50 states (California: oral tablet only, no injectable) | 48 states |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #30 | #36 |
Curex
81/100Where the value is
- Discounted first month well below the ongoing rate — $49 for semaglutide, $149 for tirzepatide
- Nationwide enrollment (all 50 states) plus an oral/sublingual route as an alternative to injections
- 365-day money-back guarantee and a full refund if never prescribed
The tradeoffs
- The '$199/mo' figure is labeled 'Starting,' not flat, and no dose-by-dose price table is published, so ask what a higher maintenance dose costs
- California residents cannot get the injectable route at all — oral tablets only, despite the 'all 50 states' enrollment claim
Regulatory note: the FDA issued a warning letter to Curex in September 2025. We still list and link to Curex; you should know the letter is on the public record before you decide.
Totara Health
80/100Where the value is
- One-month plans are priced on the product page before any intake: $190 for semaglutide and $239 for tirzepatide, the same at every dose
- Semaglutide comes as an injection, oral drops or an under-the-tongue tablet; tirzepatide as an injection or under-the-tongue tablet
- Names its dispensing pharmacy (Manifest Pharmacy in Greer, South Carolina) and its clinician network (MD Integrations)
The tradeoffs
- The lower monthly figures ($133, $119 and $99 for semaglutide) require a 3-, 6- or 12-month plan paid in one charge up front
- The banner says all 50 states, but the FAQ's state list leaves out Alaska and Mississippi
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.